COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation

Bone

Volumn 46, Issue 2, 2010, Pages 479-486

  Jeong, Byung Chul ^a   Kim, Hyun Joo ^a   Bae, In Ho ^a   Lee, Kkot Nim ^a   Lee, Kwang Youl ^b   Oh, Won Mann ^a   Kim, Sun Hun ^a   Kang, In Chol ^a   Lee, Shee Eun ^a   Koh, Gou Young ^c   Kim, Kyung Keun ^d   Koh, Jeong Tae ^a  

^a Chonnam National University   (South Korea)

^b Chonnam National University   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d Chonnam National University Medical School   (South Korea)

Author keywords

Angiogenesis; Bone formation; Bone morphogenetic protein; COMP Ang1; Tie2

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; ASCORBIC ACID; CARTILAGE OLIGOMERIC MATRIX PROTEIN ANGIOPOIETIN 1; CD31 ANTIGEN; GLYCEROL 2 PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCALCIN; PROTEIN KINASE B; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SMAD PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMINERALIZATION; BONE DESTRUCTION; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; FRACTURE; GENE EXPRESSION; IMMUNOFLUORESCENCE TEST; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANGIOPOIETIN-1; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOGENESIS; PHOSPHORYLATION; RECEPTOR, TIE-2; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 74249106462     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.09.019     Document Type: Article

References (31)

1. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5 (1999) 623-628
2. Peng H., Wright V., Usas A., Gearhart B., Shen H.C., Cummins J., and Huard J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. 110 (2002) 751-759
3. Young B.H., Peng H., and Huard J. Muscle-based gene therapy and tissue engineering to improve bone healing. Clin. Orthop. Relat. Res. (2002) S243-251
4. Tang C.H., Yang R.S., Chien M.Y., Chen C.C., and Fu W.M. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Eur. J. Pharmacol. 579 (2008) 40-49
5. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis?. Nat. Med. 6 (2000) 1102-1103
6. Isner J.M., and Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103 (1999) 1231-1236
7. Asahara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M., Yancopoulos G.D., and Isner J.M. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83 (1998) 233-240
8. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., and McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
9. Cho C.H., Kammerer R.A., Lee H.J., Steinmetz M.O., Ryu Y.S., Lee S.H., Yasunaga K., Kim K.T., Kim I., Choi H.H., Kim W., Kim S.H., Park S.K., Lee G.M., and Koh G.Y. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5547-5552
10. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., and Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3(-Kinase/Akt signal transduction pathway. Circ. Res. 86 (2000) 24-29
11. Kim K.T., Choi H.H., Steinmetz M.O., Maco B., Kammerer R.A., Ahn S.Y., Kim H.Z., Lee G.M., and Koh G.Y. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J. Biol. Chem. 280 (2005) 20126-20131
12. Cho C.H., Sung H.K., Kim K.T., Cheon H.G., Oh G.T., Hong H.J., Yoo O.J., and Koh G.Y. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 4946-4951
13. Chen D., Ji X., Harris M.A., Feng J.Q., Karsenty G., Celeste A.J., Rosen V., Mundy G.R., and Harris S.E. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J. Cell. Biol. 142 (1998) 295-305
14. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., and Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell. Biol. 127 (1994) 1755-1766
15. Chen D., Zhao M., Harris S.E., and Mi Z. Signal transduction and biological functions of bone morphogenetic proteins. Front. Biosci. 9 (2004) 349-358
16. Chen D., Zhao M., and Mundy G.R. Bone morphogenetic proteins. Growth Factors 22 (2004) 233-241
17. Ghosh-Choudhury N., Abboud S.L., Nishimura R., Celeste A., Mahimainathan L., and Choudhury G.G. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J. Biol. Chem. 277 (2002) 33361-33368
18. Suzuki T., Miyamoto T., Fujita N., Ninomiya K., Iwasaki R., Toyama Y., and Suda T. Osteoblast-specific Angiopoietin 1 overexpression increases bone mass. Biochem. Biophys. Res. Commun. 362 (2007) 1019-1025
19. Lee H.J., Bae S.W., Koh G.Y., and Lee Y.S. COMP-Ang1, angiopoietin-1 variant protects radiation-induced bone marrow damage in C57BL/6 mice. J. Radiat. Res. (Tokyo) 49 (2008) 313-320
20. Puleo D.A. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro. J. Cell. Physiol. 173 (1997) 93-101
21. Sonobe J., Okubo Y., Kaihara S., Miyatake S., and Bessho K. Osteoinduction by bone morphogenetic protein 2-expressing adenoviral vector: application of biomaterial to mask the host immune response. Hum. Gene. Ther. 15 (2004) 659-668
22. Jeong B.C., Lee Y.S., Park Y.Y., Bae I.H., Kim D.K., Koo S.H., Choi H.R., Kim S.H., Franceschi R.T., Koh J.T., and Choi H.S. The orphan nuclear receptor estrogen receptor-related receptor gamma negatively regulates BMP2-induced osteoblast differentiation and bone formation. J. Biol. Chem. 284 (2009) 14211-14218
23. Peng H., Usas A., Olshanski A., Ho A.M., Gearhart B., Cooper G.M., and Huard J. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J. Bone Miner. Res. 20 (2005) 2017-2027
24. Moutsatsos I.K., Turgeman G., Zhou S., Kurkalli B.G., Pelled G., Tzur L., Kelley P., Stumm N., Mi S., Muller R., Zilberman Y., and Gazit D. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol. Ther. 3 (2001) 449-461
25. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., and Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534
26. Guicheux J., Lemonnier J., Ghayor C., Suzuki A., Palmer G., and Caverzasio J. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone Miner. Res. 18 (2003) 2060-2068
27. Kozawa O., Hatakeyama D., and Uematsu T. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts. J. Cell. Biochem. 84 (2002) 583-589
28. Sugimori K., Matsui K., Motomura H., Tokoro T., Wang J., Higa S., Kimura T., and Kitajima I. BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J. Bone Miner. Metab. 23 (2005) 411-419
29. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90 (2002) 1243-1250
30. Schliemann C., Bieker R., Padro T., Kessler T., Hintelmann H., Buchner T., Berdel W.E., and Mesters R.M. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia. Haematologica 91 (2006) 1203-1211
31. Iwama A., Hamaguchi I., Hashiyama M., Murayama Y., Yasunaga K., and Suda T. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem. Biophys. Res. Commun. 195 (1993) 301-309